285 related articles for article (PubMed ID: 10446996)
1. Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.
Harada H; Nakagawa K; Iwata S; Saito M; Kumon Y; Sakaki S; Sato K; Hamada K
Cancer Res; 1999 Aug; 59(15):3783-9. PubMed ID: 10446996
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer.
Bouvet M; Ellis LM; Nishizaki M; Fujiwara T; Liu W; Bucana CD; Fang B; Lee JJ; Roth JA
Cancer Res; 1998 Jun; 58(11):2288-92. PubMed ID: 9622060
[TBL] [Abstract][Full Text] [Related]
3. Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells.
Harada H; Nakagawa K; Saito M; Kohno S; Nagato S; Furukawa K; Kumon Y; Hamada K; Ohnishi T
Cancer Lett; 2003 Feb; 191(1):109-19. PubMed ID: 12609716
[TBL] [Abstract][Full Text] [Related]
4. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro.
Chintala SK; Fueyo J; Gomez-Manzano C; Venkaiah B; Bjerkvig R; Yung WK; Sawaya R; Kyritsis AP; Rao JS
Oncogene; 1997 Oct; 15(17):2049-57. PubMed ID: 9366522
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
Saleh M; Stacker SA; Wilks AF
Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
8. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
[TBL] [Abstract][Full Text] [Related]
9. The growth inhibition of hepatoma by gene transfer of antisense vascular endothelial growth factor.
Kang MA; Kim KY; Seol JY; Kim KC; Nam MJ
J Gene Med; 2000; 2(4):289-96. PubMed ID: 10953920
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo.
Riccioni T; Cirielli C; Wang X; Passaniti A; Capogrossi MC
Gene Ther; 1998 Jun; 5(6):747-54. PubMed ID: 9747454
[TBL] [Abstract][Full Text] [Related]
11. RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo.
Claudio PP; Stiegler P; Howard CM; Bellan C; Minimo C; Tosi GM; Rak J; Kovatich A; De Fazio P; Micheli P; Caputi M; Leoncini L; Kerbel R; Giordano GG; Giordano A
Cancer Res; 2001 Jan; 61(2):462-8. PubMed ID: 11212232
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo.
Im SA; Gomez-Manzano C; Fueyo J; Liu TJ; Ke LD; Kim JS; Lee HY; Steck PA; Kyritsis AP; Yung WK
Cancer Res; 1999 Feb; 59(4):895-900. PubMed ID: 10029081
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
Deryugina EI; Soroceanu L; Strongin AY
Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
[TBL] [Abstract][Full Text] [Related]
14. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in malignant gliomas.
Plate KH; Risau W
Glia; 1995 Nov; 15(3):339-47. PubMed ID: 8586468
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.
Catalano A; Romano M; Martinotti S; Procopio A
Oncogene; 2002 Apr; 21(18):2896-900. PubMed ID: 11973650
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
[TBL] [Abstract][Full Text] [Related]
18. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect.
Nishizaki M; Fujiwara T; Tanida T; Hizuta A; Nishimori H; Tokino T; Nakamura Y; Bouvet M; Roth JA; Tanaka N
Clin Cancer Res; 1999 May; 5(5):1015-23. PubMed ID: 10353734
[TBL] [Abstract][Full Text] [Related]
19. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression.
Mukhopadhyay D; Tsiokas L; Sukhatme VP
Cancer Res; 1995 Dec; 55(24):6161-5. PubMed ID: 8521408
[TBL] [Abstract][Full Text] [Related]
20. Effects of tumor suppressor gene (p53) on brain tumor angiogenesis and expression of angiogenic modulators.
Tse V; Yung Y; Santarelli JG; Juan D; Hsiao M; Haas M; Harsh G; Silverberg G
Anticancer Res; 2004; 24(1):1-10. PubMed ID: 15015569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]